Clair Health Secures $11.6M for Game-Changing Noninvasive Hormone Monitor

Clair Health, a San Francisco startup, raised $11.6 million in funding for its innovative noninvasive hormone monitor aimed at women. The device, set to ship in November, uses advanced biosensors to track hormonal cycles. Co-founded by Stanford graduates, the startup boasts a 25,000-person waitlist. However, peer-reviewed validation is still pending. Privacy features ensure user data security. The femtech market is projected to grow significantly, indicating renewed investor interest.